Astronics (ATRO) delivered one of its cleanest operating quarters in years. Adjusted earnings of $0.81 per share beat the $0.70 consensus by 15.7% and grew 65.3% year over year. Revenue rose 28.5% to a record $271.68 million, 1.0% above the $268.9 million estimate and ahead of the 22.5% year-to-date pace. Third-quarter growth therefore ran faster than the first half. The central development is margin. Adjusted operating margin climbed to 18.8% from 16.6% in Q2 and 12.8% in Q1, which means management reached the high-teens target it set at the start of the year. The tension is that the forward signals did not improve alongside profitability. Management held full-year revenue guidance at $1.02-$1.04 billion rather than raising it. Bookings also cooled, and the stock entered the report down 30% since the post-Q2 open.

The quality of the beat holds up better than the GAAP figures suggest. GAAP EPS of $1.08, compared with a $0.26 loss a year ago, was inflated by about $5.3 million of legal recoveries tied to the favorable UK patent appeal and a separate settlement. A tax benefit also helped: the company recorded a $0.2 million tax benefit on $52 million of pretax income. Management's adjusted figures strip out the legal gains and apply a normalized 25% tax rate. That leaves $0.81 as the more representative figure. However, adjusted results still include $1.9 million of tariff refunds, which flattered a 410-basis-point gross margin expansion to 34.6%. Even after these items, the underlying leverage is real:

• Adjusted Aerospace margin rose to 22.5% from 21.4% in Q2.
• Adjusted EBITDA margin reached a record 21.8%.
• Test Systems swung to a 14.7% operating margin from roughly break-even in Q2.

The operating mix is broad. Commercial Transport grew 28.8%, General Aviation jumped 51.7% on IFEC demand, and Seat Motion more than doubled. In Test, the Army TS-4549/T radio test program contributed $5.3 million. Management expects it to reach roughly $9-10 million per quarter at full-rate production in early 2027, despite a $2.2 million negative revision on mass transit contracts. Cash conversion lagged the earnings story. Operating cash flow slipped to $25.8 million from $30.1 million in Q2 as receivables and inventory built ahead of expected 2027 growth, and quarter-end cash was just $7.9 million. Long-term debt still fell $25.6 million sequentially to $284.8 million, and liquidity rose to $278 million.

The softer details sit in the outlook. Fourth-quarter guidance of $255-$275 million implies a sequential step back, on customer scheduling, from a quarter that management had previously expected to step up modestly. The range is also wider than usual. Consolidated book-to-bill slowed to 1.00 from 1.26 in Q1 and about 1.18 in Q2, leaving backlog flat at $780 million. Aerospace book-to-bill of 1.05 and a record $670 million Aerospace backlog soften that picture. Test's 0.49 ratio follows a 2.78 Q2 that included large awards. Several risks emerged on the call:

• Bell is re-planning the MV75/FLARA program after earlier talk of acceleration, trimming 2026 to about $35 million and holding 2027 flat.
• Memory and electronics supply is tightening because of data center demand, stretching lead times and raising prices.
• The expected deferred tax valuation allowance release was narrowed to $35-$40 million.

Against that, management offered a first look at 2027 of "strong double-digit" growth, which it clarified as well north of 10%, with roughly 40% incremental margins. It also flagged missile program pricing and capacity work as a potential multi-year upside, and said low-Earth-orbit connectivity positioning should become clearer by year-end. The capex cut to $25-$30 million from $40-$45 million was attributed to timing, not reduced investment.

The market had been pricing in deceleration well before the print. Shares peaked at $94.46 on August 13, just after the Q2 report. They then slid to an inter-earnings low of $52.00 on November 5 and closed at $58.99 the day before results, about 20% below the 200-day moving average of $73.61. Investor sentiment remained positive but weakened modestly, to 0.33 from 0.38. The Earnings Whispers trend readings are split along the same lines: sequential growth and momentum are positive, while price and AVWAP trends remain negative.

The bottom line is that Astronics executed on the profitability promise investors were waiting for, and the 2027 framework preserves a credible growth story. However, flat guidance, a sequential Q4 dip, slowing bookings and the MV75 reset give bears legitimate ammunition. Stronger order momentum likely matters more for the stock's next leg than another margin beat.